Mice with MYBPC3 gene knockout or mutation, when treated with AAV-MYBPC3 gene transfer, demonstrated improvement of cardiac function and long-term prevention of cardiac hypertrophy [69–71]. Here, MYBPC3 is linked to cardiac hypertrophy.